RAB1A and lung carcinoma: Although Rab1A was successfully knocked down in a panel of lung cancer cell lines, no changes were observed with regards to mTORC1 (P-S6K1(T389)) or mTORC2 (P-AKT (S473)) signaling (Figure 3A).